고온에서 HAN 계열 추진제 액적의 거동에 대한 연구

황창환(Chang Hwan Hwang),백승욱(Seung Wook Baek),한조영(Cho Young Han),김수겸(Su Kyum Kim),전형열(Hyung Yeol Jeon) 한국연소학회 2012 KOSCOSYMPOSIUM논문집 Vol.- No.45

The droplet behavior of 83.9 wt.% HAN water solution was investigated experimentally with various ambient temperature and nitrogen environment. At the initial stage of evaporation under thermal decomposition temperature of HAN, gradual decreasing of droplet diameter was observed. After that, the droplet started to expand due to the internal pressure build up by water nucleation inside the droplet. The micro explosion was observed at higher temperature than the decomposition temperature of HAN and the remaining droplet showed similar behavior of single composition droplet. The decreasing rate was augmented as the ambient temperature increasing.

Simplified Effective Compressive Strengths of Columns with Intervening Floor Slabs

Seung?Ho Choi,Jin?Ha Hwang,Sun?Jin Han,Hae?Chang Cho,Jae Hyun Kim,Kang Su Kim 한국콘크리트학회 2020 International Journal of Concrete Structures and M Vol.14 No.5

The current design codes discuss the effective compressive strengths of columns, which reflect a decrease in load transfer performance that can occur when columns and slabs have different concrete compressive strengths. The effective compressive strength of a column increases as it is confined by the slab, and the design codes mandate three different effective compressive strengths for interior columns (confinement on four sides), exterior columns (confinement on three sides), and corner columns (confinement on two sides). For both corner and exterior columns, the confinement effect of the slab is significantly smaller than that for the interior column, and there is a more marked decrease in load transfer performance. However, there is still a lack of theoretical studies investigating the effective compressive strengths of the corner and exterior columns. Therefore, based on the analysis model established in previous research, this study has proposed an equation for calculating the effective compressive strengths of the corner, exterior and isolated columns without any confinement effects of the slab. In addition, axial loading tests of isolated columns were conducted and the proposed equation was verified.

요골동맥을 통한 관상동맥촬영 중 진단된 편위된 우측쇄골하동맥 1예

한승희,김수영,박혜경,박종성 영남대학교 의과대학 2012 Yeungnam University Journal of Medicine Vol.29 No.1

The left aortic arch with an aberrant right subclavian artery, or arteria lusoria, is the most common aortic arch anomaly, occurring in 0.5-2.5% of individuals. In such cases, the angular course of the arteria lusoria to the ascending aorta imposes difficulty in passing a guide wire to the ascending aorta during right transradial catheterization. Here, the case of a 53-year-old woman with intermittent chest tightness and coughing is reported. Aberrant right subclavian artery(arteria lusoria) was diagnosed via aortogram during right trans- radial coronary angiography. Compression of the esophagus and trachea by the aberrant right subclavian artery was demonstrated by chest computed tomography(CT).

가시광을 이용한 ZnS/ZnO 상에서의 광촉매 반응에 의한 물로부터의 수소생성

서승광,윤필상,이한수,이호인 한국공업화학회 2003 응용화학 Vol.7 No.2

The pure ZnS can not absorb visible light because of its large band gap of 3.6eV. The ZnO/ZnS was obtained from partial oxidation of ZnS, and its band gap was 2.5eV where visible light can be absorbed. From XRD analysis, it was confirmed that only ZnO was formed during oxidation process but not ZnSO₄. In case of ZnO/ZnS, the quantum efficiency for the hydrogen evolution from water was 0.87% under visible light irradiation. In order to improve the interaction between ZnO and ZnS, ZnS/ZnO was prepared by precipitating ZnS on ZnO. After calcination of ZnS/ZnO, the band gap became narrow. The pure ZnO and the physically mixed ZnS-ZnO could not absorb visible light, but the ZnS-doped ZnO (ZnS/ZnO) could do. The band gap of pure ZnO was 3.2 eV and that of ZnS/ZnO was 2.5ev. The best activity was obtained when clcination temperature and time were 500 ℃ and 1 h, respectively. The quantum efficiency of ZnS/ZnO for the reaction was 3.29%.

유방암에서 PCNA, c-erbB-2 그리고 p53의 표출양상에 관한 연구

김득수,김의한,양승하 순천향의학연구소 1999 Journal of Soonchunhyang Medical Science Vol.5 No.2

Breast carcinoma is a common malignant tumor in korea. Various oncogenes have been found in malignant tumor cells. There were many reports for correlation betwee PCNA, c-erbB-2, and p53, and prognosis of breast carcinoma, but is controversial. We performed immunohistochemical stain for PCNA, c-erbB-2, and p53 for 27 cases of benign tumor and 49 cases of carcinoma of the breast and evaluated expression rate of each antigens, and we compared their correlation with prognosis of patients in breast carcinoma. The results were as follow; 1) PCNA LI of benign tumor and carcinoma of breast were 74.04±17.85 and 71.86±21.57. c-erbB-2 expression rates were 85.19% and 79.59%, and p53 were 0% and 51.02%. 2) PCNA LI showed no difference according to types of benign tumor and to types, histologic grade, and lymph node metastatic status of carcinoma. 3) c-erbB-2 showed higher expression rate in grade Ⅱ(87.5%) and grade Ⅲ(88.89%) than grade Ⅰ(62.50%) in breast carcinoma but it was not significant difference. 4) p53 showed significantly higher expression rate in left side and non-metastatic cases compared to right side and metastatic cases(each p<0.05), and it showed increasing expression rate according to highening of grade without significant differnece(p=0.069). 5) The expression of p53 in breast carcinoma showed significant correlation with proliferative activity of tumor cells(P<0.05). Above results showed that there was correlation the expression of p53 and poor prognosis of patients and proliferative activity of tumor cells in breast carcinoma. c-erbB-2 showed indistinctive correlation with prognosis and no correlation with proliferative activity of tumor cells. PCNA showed no relation to prognosis

달리기 시 운동화 중저의 경도가 신발굴곡각도의 크기에 미치는 영향

목승한,곽창수,권오복 한국운동역학회 2004 한국운동역학회지 Vol.14 No.2

S. H. MOK, C. S. KWAK, O. B. KWON. The Influence of Midsole Hardness of Running Shoes on Shoes Flex Angle during Running. Korean Journal of Sport Biomechanics, Vol. 14, No. 2, pp. 85-103, 2004. This study was conducted to determine what effects would the midsole hardness of running shoes have on shoe flex angle and maximum propulsive force. Furthermore, the relationship between the shoes flex angle and maximum propulsive force was elucidated in order to provide basic data for developing running shoes to improve sports performances and prevent injuries. The subjects employed in the study were 10 college students majoring in physical education who did not have lower limbs injuries for the last one year and whose running pattern was rearfoot strike pattern of normal foot. The shoes used in this study had 3different hardness, shore A 40(soft), 50(medium) and 60(hard). The subjects were asked to run at a speed of 4?.08m/sec, and their movements were videotaped with 2 S-VHS video-cameras and measured with a force platform. And the following results were obtained after analyzing and comparing the variables. 1. Although the minimum angle of shoes flex angle was estimated to appear at SFA4, it appeared at SFA2 except in those shoes with the hardness of 40. 2. The minimum angle of shoes flex angle was 145.1?with barefoot. Among the shoes with different hardness, it was the smallest when the hardness was 50 at 149.9? The time to the minimum angle was 70.7% of the total ground contact time. 3. Maximum propulsive force according to midsole hardness was the largest when the hardness was 50 at 1913.9?84.3N. There was a low correlation between maximum propulsive force and shoes flex angle.

퍼지제어에 의한 태양전지의 최대출력점 추적제어

김종수,성낙규,이승환,강승욱,한경희 명지대학교 대학원 1997 대학원논문집 Vol.1 No.-

The solar cells should be operated at the maximum power point because its output characteristics are greatly fluctuate on the variations of insolation, temperature and loads. To obtain maximum power from solar cell, photovoltaic system cell power system usually requires maximum power point tracking controller. This paper propose Maximum power point tracking method by power compare and fuzzy control. The power compare method have got fault that is oscillation and speed of trace at maximum power point. To solve two problem of the power compare method, designed fuzzy controller logic traces maximum power point without variations of insolation, temperature and loads.

N세대의 스포츠 소비유형 요인 분석

이현수,한성유,박소영 釜山大學校 附設 體育科學硏究所 2004 體育科學硏究所 論文集 Vol.20 No.-

The purpose of this study was to develop actual measurement tool on the Sports Consume type factor analysis of N generation.....

소아에서의 급성 파종성 뇌척수염의 임상적 고찰

조수진,박은애,유은선,김혜순,손세정,서정완,이승주,한후재 이화여자대학교 의과대학 2003 EMJ (Ewha medical journal) Vol.26 No.2

목적: 급성 파종성 뇌척수염은 감염이나 예방 접종 후 발생하는 중추 신경계의 급성 자가 면역 염증성 질환으로 탈수초를 일으킨다. 신경학적인 증상으로 발현되고 대부분 환전히 회복되지만 신경학적 후유증을 남기거나 사망 할 수도 있다. 이에 저자들은 본원에서 발생 한 14명을 분석하여 조기 진단과 치료에 도움을 주고자 하였다. 대상과 방법: 1998년 3월부터 2003년 8월까지 이대목동병원에서 급성 파종성 뇌척수염으로 진단 받은 14명의 의무기록을 후향적으로 조사하였다. 결과: 환자들의 평균 발생 연령은 5±7.8개월이였고, 특정계절이나 연도에 집중되어서 나타나지는 않았다. 선행질환은 주로 비특이적인 상기도 감염이 가장 많았고, 초기증상으로는 경련이 가장 많았다. 그 외에 의식저하나 운동장애도 있었다. 뇌척수액 검사에서 백혈구 증가증이 발견된 경우는 있었으나 단백이 증가된 경우는 없었다. 뇌 자기공명 촬영에서 T2 증강시 뇌백질과 기저핵에 고음영의 다발성 병소가 발견되었고 추적 촬영에서 대부분에서 소실되었다. 뇌파 검사가 시행되었던 경우 전반적인 서파가 가장 많았고 국소적인 극파가 나온 경우도 한 명 있었다. 환자들은 정맥 면역 글로블린과 메틸프레드니졸론으로 치료하였고 치료 시작 후 3~7일내 증상이 호전되었다. 모든 환자를 2달 이상 추적 관찰하였고 항경련제가 지속적으로 필요한 정도의 경련성 질환이 두 명, 신경아교증이 남아잇는 경우가 한 명, 외래에서 다발성 경화증이 의심되는 경우가 한 명 있었다. 결론: 급성 파종성 뇌척수염은 침범 부위에 따라서 다양한 임상 상으로 나타나며 면역 글로블린과 메틸프레드니졸론이 치료에 효과적이였다. 본 연구에서는 대상 환자수가 적어 신경학적 후유증의 위험요소는 밝힐 수는 없으나, 예후는 검사소견과 연관되어 있지는 않았고, 대부분에서 양호하여 완전히 회복되었으나, 신경학적 후유증이 남은 경우도 있었다. Objective:Acute disseminated encephalomyelitis(ADEM) is an acute demyelinating autoimmune inflammatory disease of the central nervous system which develops after infection of vaccination. It may be fatal, and produce a permanent residual static disability or fully recover. We retrospec-tively studied 14 cases to investigate the clinical findings and outcome of ADEM. Methods : 14cases of ADEM diagnosed at Ewha Womans University Mokdong Hospital from 1998 to 2003 were retrospectively reviewed. Results : The age of onset was 5years±7.8 months and no seasonal clustering was found. The time of onset of symptoms was between 3 to 30 days. The preceding events were nonspecific upper respiratory infections in 9 cases, aseptic meningitis in 4 cases, and gastroenteritis in one case..The initial symptoms were seizure, altered consciousness, hemiparesis, fever, headache, and vomiting. Brain MRI showed multifocal high signal intensity lesions on T2 weighted image mainly in the cerebral whith matter, basal ganglia and periventricular white matter. EEG was performed in some cases and showed generalized or focal slow waves and only one case showed focal spikes. Patients were treated with IV globulin and methylprednisolone and the symptoms improved within 3-7 days after treatment. All patients were followed up for more than 2 months and most of them fully recovered except two. Conclusion : ADEM presents in various clinical manifestations depending on its involvement of the brain lesions. Most cases recovered fully but in some cases, residual permanent neurologic sequelae remained.

고콜레스테롤 혈증 환자에서 Cerivastatin(LIPOBAY, 의과학연구소)의 임상효과 및 안전성에 관한 연구

박성훈,김미연,정수진,이영숙,박창한,변은경,전성희 梨花女子大學校 醫科大學 醫科學硏究所 2001 EMJ (Ewha medical journal) Vol.24 No.3

목적 : Cerivastatin(LIPOBAY)은 최근에 개발되어 사용되기 시작한 HMG-CoA 환원효소 억제제로서 저용량으로 탁월한 콜레스테롤 강하효과를 보이는 약물이다. 저자들은 Cerivatatin(LIPOBAY)의 혈중 콜레스테롤 강하효과를 평가하고 약물의 안전성을 평가하기 위하여 본 연구를 시행하였다. 방법 : 고콜레스테롤혈증 환자 37명(남자 13명, 여자 24명)을 대상으로 하였다. 대상환자는 2주간의 저콜레스테롤 식이 후에도 혈청 콜레스테롤이 240㎎/㎗이상이거나, 관상동맥질환이 있는 환자는 혈청콜레스테롤이 220㎎/㎗이상인 경우 cerivastatin 0.4㎎을 8주간 복용하도록 하였다. 임상적 관찰과 검사실 검사(간기능검사, 일반혈액검사, 혈청지질검사)는 투약개시 후 4주 및 8주 후에 시행하였다. 결과 : Cerivastatin 0.4㎎을 4주간 투여한 후 측정한 LDL 콜레스테롤, 총콜레스테롤, triglyceride, 및 HDL 콜레스테롤은 각각 38%, 28.8%, 11.6% 및 7.8% 감소하였다. 총콜레스테롤/HDL 콜레스테롤 비 및 LDL/HDL비는 각각 20.8% 및 31.1% 감소하였다. 투약 8주후에 측정한 검사소견은 4주후에 비해 유의한 변화를 보이지 않았다. 한명의 환자(2.7%)에서 간기능 검사상 AST, 및 ALT의 지속적인 상승으로 투약을 중지하였다. 결론 : Cerivastatin 0.4㎎/day는 혈청콜레스테롤을 효과적으로 감소시켰으며 심각한 부작용은 볼 수 없었다. 따라서 적극적으로 LDL콜레스테롤을 낮출 필요가 있는 고콜레스테롤혈증 환자에서 cerivastatin은 효과적이고 안전한 약물이라고 생각된다. Objectives : Cerivastain(LIPOBAY) is recently developed HMG-CoA reductase inhibitor which is effective in lowering serum cholesterol levels at microgram does. We evaluated the clinical efficacy and safety of cerivastatin(LIPOBAY) in patients with hypercholesterolemia. Method : Thirty-seven patients(male : 13, female : 24) with hypercholesteolemia defined as baseline serum total cholesterol ≥240㎎/㎗, or ≥220㎎/㎗ in patients with known coronary artery disease were included for this study. After 2 weeks of low cholesterol diet, if the serum total choesterol level meet the criteria, cerivastain 0.4㎎/day was prescribed for 8 weeks. Clinical follow-up and laboratory tests were performed 4 weeks and 8 weeks after medication. Results : After 4 weeks of cerivastain 0.4㎎/day treatment, low density lipoprotein(LDL) cholesterol decreased 38% and total cholesterol decreased 28.8% from baseline. Triglyceride decreased 11.6%, and high density lipoprotein(HDL) cholesterol decreased 7.8% from baseline. Total cholesterol/HDL ratio decreased 20.8% and LDL/HDL ratio decreased 31.1% from baseline. After 8 weeks of treatment, no further significant changes were noted compared with the values at 4 weeks. Cervastatin was discontinued in one patient(2.7%) due to continuous liver enzyme elevation. Conclusion : Cerivastatin 0.4㎎/day is effective in lowering serum cholesterol levels without significant adverse reactions. Cerivastatin is effective and safe for patients with hypercholesterolemia who needs aggressive LDL cholesterol lowering.